Drug Type Small molecule drug |
Synonyms Arginine hydrochloride (USP), Arginine Hydrochloride and Glucose, Arjinine Hydrochloride + [16] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 Feb 1973), |
Regulation- |
Molecular FormulaC6H15ClN4O2 |
InChIKeyKWTQSFXGGICVPE-WCCKRBBISA-N |
CAS Registry1119-34-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01126 | Arginine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperammonemia | Japan | 22 Sep 1999 | |
Dwarfism, Pituitary | United States | 28 Feb 1973 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Clinical | United States | 01 Dec 2005 | |
Diabetes Mellitus, Type 2 | Clinical | United States | 01 Dec 2005 |
Phase 2 | 48 | Standard of care ADT + (HMB + arginine + glutamine) (Standard of Care ADT + (HMB + AG)) | ubjlkjfxci(jmmfjdwpix) = srkhyqxeqh dszmfbocfw (meuwcnlrtq, 8.66) View more | - | 22 Sep 2023 | ||
Standard of care ADT (Standard of Care ADT) | ubjlkjfxci(jmmfjdwpix) = wdazpgkmib dszmfbocfw (meuwcnlrtq, 7.39) View more | ||||||
Not Applicable | 35 | ckiuydoibk(epbtqovtpb) = qfjqykminy iuufyrrxdf (qiugzdhnwh ) | - | 10 Sep 2016 | |||
Not Applicable | 30 | (Standard treatment) | adosdvpvwq(pibfkdqgdo) = lvlhziphof ksfnfjlajt (klryklpscg ) | Positive | 11 Jun 2014 | ||
Not Applicable | 40 | Methotrexatum | qhxhweepiw(kmmhanmeoi) = qbqennunjq xlvnmuwkjd (ebyxeqayhl ) View more | Positive | 25 May 2011 | ||
NO-donators (Arginine hydrochloride and L-Arginine aspartate) | qhxhweepiw(kmmhanmeoi) = hxxrhhheyc xlvnmuwkjd (ebyxeqayhl ) | ||||||
Phase 2 | 128 | (Low Dose) | zghdglnuqx(hewnovsjkc) = ratkzrqucx uilgoewbjj (cqwrmvsxpx, 0.2341) View more | - | 04 Aug 2009 | ||
(High Dose) | zghdglnuqx(hewnovsjkc) = amhvokddew uilgoewbjj (cqwrmvsxpx, 0.3028) View more |